Literature DB >> 25896697

Influence of linker length and composition on enzymatic activity and ribosomal binding of neomycin dimers.

Derrick Watkins1, Sunil Kumar2, Keith D Green3, Dev P Arya4, Sylvie Garneau-Tsodikova5.   

Abstract

The human and bacterial A site rRNA binding as well as the aminoglycoside-modifying enzyme (AME) activity against a series of neomycin B (NEO) dimers is presented. The data indicate that by simple modifications of linker length and composition, substantial differences in rRNA selectivity and AME activity can be obtained. We tested five different AMEs with dimeric NEO dimers that were tethered via triazole, urea, and thiourea linkages. We show that triazole-linked dimers were the worst substrates for most AMEs, with those containing the longer linkers showing the largest decrease in activity. Thiourea-linked dimers that showed a decrease in activity by AMEs also showed increased bacterial A site binding, with one compound (compound 14) even showing substantially reduced human A site binding. The urea-linked dimers showed a substantial decrease in activity by AMEs when a conformationally restrictive phenyl linker was introduced. The information learned herein advances our understanding of the importance of the linker length and composition for the generation of dimeric aminoglycoside antibiotics capable of avoiding the action of AMEs and selective binding to the bacterial rRNA over binding to the human rRNA.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896697      PMCID: PMC4468663          DOI: 10.1128/AAC.00861-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Binding of dimeric aminoglycosides to the HIV-1 rev responsive element (RRE) RNA construct.

Authors:  J B Tok; L J Dunn; R C Des Jean
Journal:  Bioorg Med Chem Lett       Date:  2001-05-07       Impact factor: 2.823

2.  Click dimers to target HIV TAR RNA conformation.

Authors:  Sunil Kumar; Patrick Kellish; W Edward Robinson; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Biochemistry       Date:  2012-03-09       Impact factor: 3.162

3.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

4.  Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.

Authors:  Reem Almaghrabi; Cornelius J Clancy; Yohei Doi; Binghua Hao; Liang Chen; Ryan K Shields; Ellen G Press; Nicole M Iovine; Bethany M Townsend; Marilyn M Wagener; Barry Kreiswirth; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

5.  The kinetic mechanism of AAC3-IV aminoglycoside acetyltransferase from Escherichia coli.

Authors:  Maria L B Magalhaes; John S Blanchard
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

6.  Effects of altering aminoglycoside structures on bacterial resistance enzyme activities.

Authors:  Keith D Green; Wenjing Chen; Sylvie Garneau-Tsodikova
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

7.  Regiospecificity of aminoglycoside phosphotransferase from Enterococci and Staphylococci (APH(3')-IIIa).

Authors:  P R Thompson; D W Hughes; G D Wright
Journal:  Biochemistry       Date:  1996-07-02       Impact factor: 3.162

Review 8.  Aminoglycoside phosphotransferases: proteins, structure, and mechanism.

Authors:  G D Wright; P R Thompson
Journal:  Front Biosci       Date:  1999-01-01

9.  A fluorescence-based screen for ribosome binding antibiotics.

Authors:  Derrick Watkins; F A Norris; Sunil Kumar; Dev P Arya
Journal:  Anal Biochem       Date:  2012-12-19       Impact factor: 3.365

10.  4'-O-substitutions determine selectivity of aminoglycoside antibiotics.

Authors:  Déborah Perez-Fernandez; Dmitri Shcherbakov; Tanja Matt; Ng Chyan Leong; Iwona Kudyba; Stefan Duscha; Heithem Boukari; Rashmi Patak; Srinivas Reddy Dubbaka; Kathrin Lang; Martin Meyer; Rashid Akbergenov; Pietro Freihofer; Swapna Vaddi; Pia Thommes; V Ramakrishnan; Andrea Vasella; Erik C Böttger
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more
  11 in total

1.  Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins.

Authors:  Alice Sosic; Irene Saccone; Caterina Carraro; Thomas Kenderdine; Elia Gamba; Giuseppe Caliendo; Angela Corvino; Paola Di Vaio; Ferdinando Fiorino; Elisa Magli; Elisa Perissutti; Vincenzo Santagada; Beatrice Severino; Valentina Spada; Dan Fabris; Francesco Frecentese; Barbara Gatto
Journal:  Bioconjug Chem       Date:  2018-06-12       Impact factor: 4.774

2.  Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin Conjugates.

Authors:  Natalya N Degtyareva; Changjun Gong; Sandra Story; Nathanael S Levinson; Adegboyega K Oyelere; Keith D Green; Sylvie Garneau-Tsodikova; Dev P Arya
Journal:  ACS Infect Dis       Date:  2017-02-17       Impact factor: 5.084

3.  Tobramycin Variants with Enhanced Ribosome-Targeting Activity.

Authors:  Marina Y Fosso; Hongkun Zhu; Keith D Green; Sylvie Garneau-Tsodikova; Kurt Fredrick
Journal:  Chembiochem       Date:  2015-06-17       Impact factor: 3.164

4.  N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.

Authors:  Girish C Sati; Dimitri Shcherbakov; Sven N Hobbie; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ACS Infect Dis       Date:  2017-04-06       Impact factor: 5.084

5.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

Review 6.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

7.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

8.  Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Microb Drug Resist       Date:  2017-12-20       Impact factor: 3.431

9.  Synthesis and Biological Activity of Mono- and Di-N-acylated Aminoglycosides.

Authors:  Nishad Thamban Chandrika; Keith D Green; Jacob L Houghton; Sylvie Garneau-Tsodikova
Journal:  ACS Med Chem Lett       Date:  2015-09-30       Impact factor: 4.345

10.  Arginine-linked neomycin B dimers: synthesis, rRNA binding, and resistance enzyme activity.

Authors:  Yi Jin; Derrick Watkins; Natalya N Degtyareva; Keith D Green; Meredith N Spano; Sylvie Garneau-Tsodikova; Dev P Arya
Journal:  Medchemcomm       Date:  2015-10-03       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.